Corbus Pharmaceuticals files non-substantive 8-K/A to correct Exhibit 5.1 signature

Corbus Pharmaceuticals Holdings, Inc.

Amendment corrects omitted conformed signature on Lowenstein Sandler LLP legal opinion filed as Exhibit 5.1.
Original 8-K filed Feb 1, 2024 remains unchanged; no new financial or business disclosures.
Underwriting agreement and two press releases from Jan 30-31, 2024 are incorporated by reference unchanged.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.